Traslational Cancer Drugs Pharma SL
🇪🇸Spain
- Country
- 🇪🇸Spain
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tcdpharma.com
Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Traslational Cancer Drugs Pharma, SL
- Target Recruit Count
- 28
- Registration Number
- NCT01215864
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath